Additionally, a study of acute lymphocytic leukemia patients that received six fractions of 2 Gy TBI showed a significant and sustained increase in blood-based Cdkn1a after each fraction [127]. This evidence concerns the gene CDKN1A and acute lymphoblastic leukemia.